As of April 2024 Glenmark Pharmaceuticals has a market cap of $3.62 Billion. This makes Glenmark Pharmaceuticals the world's 3127th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $3.62 B | 25.1% |
2023 | $2.90 B | 100.49% |
2022 | $1.44 B | -27.78% |
2021 | $2.00 B | 5.25% |
2020 | $1.90 B | 38.39% |
2019 | $1.37 B | -50.78% |
2018 | $2.79 B | 6.58% |
2017 | $2.62 B | -28.98% |
2016 | $3.69 B | -5.74% |
2015 | $3.91 B | 18.74% |
2014 | $3.29 B | 40.88% |
2013 | $2.34 B | -10.31% |
2012 | $2.60 B | 76.06% |
2011 | $1.48 B | -32.21% |
2010 | $2.18 B | 46.83% |
2009 | $1.48 B | -2.8% |
2008 | $1.53 B | -57.98% |
2007 | $3.64 B | 348.88% |
2006 | $0.81 B | 96.44% |
2005 | $0.41 B |
On Apr 24th, 2024 the market cap of Glenmark Pharmaceuticals was reported to be: